Show Health and Fitness Publications

Wed, February 1, 2012

[ Wed, Feb 01st 2012 ] - Market Wire

Pfizer and GlaxoSmithKline Optimistic on Growth Prospects

[ Wed, Feb 01st 2012 ] - Market Wire

AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference

[ Wed, Feb 01st 2012 ] - Market Wire

Aethlon Medical Reports Immediate and Rapid Virol .. C (HCV) Patients Receiving Hemopurifier Treatment

[ Wed, Feb 01st 2012 ] - Market Wire

MedCath Corporation to Release First Quarter Results in Quarterly SEC Filing

[ Wed, Feb 01st 2012 ] - Market Wire

Shire and Sangamo Collaborate to Develop Therapeu .. atment of Hemophilia and Other Monogenic Diseases

[ Wed, Feb 01st 2012 ] - Market Wire

Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference

[ Wed, Feb 01st 2012 ] - Market Wire

Implant Sciences' Quantum Sniffer QS-H150 Securit .. to Major Oil Corporation for Deployment in Africa

[ Wed, Feb 01st 2012 ] - Market Wire

Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer

[ Wed, Feb 01st 2012 ] - Market Wire

OncoSec President and CEO Contributes to Physicians News Digest

[ Wed, Feb 01st 2012 ] - Market Wire

PAREXEL and ASAN Medical Center Establish Allianc .. d Drug Development and Commercialization Programs

[ Wed, Feb 01st 2012 ] - Market Wire

Concord Medical Services Holdings Limited Engages .. p LLC to Establish a Strategic Investor Relations

Tue, January 31, 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Generex Announces $2.00 Million Capital Investment

[ Tue, Jan 31st 2012 ] - Market Wire

KineMed annuncia di aver stretto una collaborazio .. per lo sviluppo di approcci innovativi al trattam

[ Tue, Jan 31st 2012 ] - Market Wire

Hospira ernennt Richard Davies zum Chief Commercial Officer

[ Tue, Jan 31st 2012 ] - Market Wire

First Case in VISIUS Surgical Theatre at Florida Hospital

[ Tue, Jan 31st 2012 ] - Market Wire

Exactech Announces Preliminary 2011 Sales of $205 .. llion and 4th Quarter 2011 Sales of $53.1 Million

[ Tue, Jan 31st 2012 ] - Market Wire

Patient Home Monitoring (PHM) Announces Audited F .. cal Quarter 2012 Results and Anticoagulation Clin

[ Tue, Jan 31st 2012 ] - Market Wire

[ Tue, Jan 31st 2012 ] - Market Wire

Dendreon, Delta Air Lines, JDS Uniphase

[ Tue, Jan 31st 2012 ] - Market Wire

Health Netas & UCLAas Health Literacy Social Media Program Opens to All Teens Nationwide

[ Tue, Jan 31st 2012 ] - Market Wire

Community Health Systems Announces Execution of A .. ate with Longview, Texas, Multi-Speciality Clinic

[ Tue, Jan 31st 2012 ] - Market Wire

Catasys Contracts With Coventry Health Care of Oklahoma

[ Tue, Jan 31st 2012 ] - Market Wire

Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies

[ Tue, Jan 31st 2012 ] - Market Wire

Biomerica Launches New Patented Test to Identify .. eloping Severe Side Effects From Thiopurine Drugs

[ Tue, Jan 31st 2012 ] - Market Wire

West to Present at UBS Conference

[ Tue, Jan 31st 2012 ] - Market Wire

Life Technologies Names Alan Sachs as Head of Global Research and Development

[ Tue, Jan 31st 2012 ] - Market Wire

AcelRx Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Biogen Idec nombra a Kenneth DiPietro Vicepresidente ejecutivo de Recursos Humanos

[ Tue, Jan 31st 2012 ] - Market Wire

Reflect Scientific, Inc. Has Positive Outlook for 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Inovio Pharmaceuticals Moves Closer to "Universal .. trating Protective Immune Responses Against Multi

[ Tue, Jan 31st 2012 ] - Market Wire

Inovio Pharmaceuticals Moves Closer to quot;&# .. luenza Vaccine by Demonstrating Protective Immune

Mon, January 30, 2012

[ Mon, Jan 30th 2012 ] - Market Wire

Greatbatch, Inc. to Participate in the 2012 Canaccord Genuity Musculoskeletal Conference

[ Mon, Jan 30th 2012 ] - Market Wire

Watson Announces New Jersey-Based Global Ramp;;D Technology Center

[ Mon, Jan 30th 2012 ] - Market Wire

ISTA's Board Reiterates Commitment to Maximizing .. hareholder Value Through Strategic Review Process

[ Mon, Jan 30th 2012 ] - Market Wire

AMAG Pharmaceuticals Announces Completion of Enro .. am Evaluating Feraheme for a Broader Iron Deficie

[ Mon, Jan 30th 2012 ] - Market Wire

Allos Therapeutics Requests Re-Examination of CHM .. FOLOTYN in PTCL at the European Medicines Agency

[ Mon, Jan 30th 2012 ] - Market Wire

Alnylam Receives Notice of Allowance from United .. ffice (USPTO) for New Patent Broadly Covering Sec

[ Mon, Jan 30th 2012 ] - Market Wire

Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources

[ Mon, Jan 30th 2012 ] - Market Wire

Community Health Systems, Inc. Finalizes Amendment and Extension of Its Credit Facilities

[ Mon, Jan 30th 2012 ] - Market Wire

Kenneth DiPietro kommt als Executive Vice President, Human Resources zu Biogen Idec

[ Mon, Jan 30th 2012 ] - Market Wire

Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.

[ Mon, Jan 30th 2012 ] - Market Wire

Revaskularisierungsgert von Covidien zur interven .. llen Behandlung bei Schlaganfallstudie zugelassen

[ Mon, Jan 30th 2012 ] - Market Wire

Compugen Presents Three Product Candidates for Tr .. s at the Immunotherapeutics & Immunomonitoring Co

[ Mon, Jan 30th 2012 ] - Market Wire

Dispositivo per la rivascolarizzazione di Covidie .. tazione interventistica sulla gestione dell'ictus

[ Mon, Jan 30th 2012 ] - Market Wire

Implant Sciences Sells Explosives Trace Detection Units for Deployment in Africa

[ Mon, Jan 30th 2012 ] - Market Wire

Covidien Revascularization Device Approved for Interventional Management of Stroke Trial

[ Mon, Jan 30th 2012 ] - Market Wire

Le dispositif de revascularisation Covidien appro .. essai visant la gestion interventionnelle des AVC

[ Mon, Jan 30th 2012 ] - Market Wire

Synageva BioPharma Highlights Key Data Presentati .. g Lysosomal Disease Network (LDN) World Symposium

[ Mon, Jan 30th 2012 ] - Market Wire

DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases

[ Mon, Jan 30th 2012 ] - Market Wire

Capital Senior Living Corporation to Present at U .. are Services Conference on Wednesday, February 8,

[ Mon, Jan 30th 2012 ] - Market Wire

Wright Medical Group, Inc. Names Daniel Garen Senior Vice President and Chief Compliance Officer

Sat, January 28, 2012

[ Sat, Jan 28th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Health Management Associates, Inc.

[ Sat, Jan 28th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.

Fri, January 27, 2012

[ Fri, Jan 27th 2012 ] - Market Wire

Bionovo to Voluntarily Delist from NASDAQ

[ Fri, Jan 27th 2012 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. nvestment in TranS1, Inc. to Inquire About the Le

[ Fri, Jan 27th 2012 ] - Market Wire

Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash

[ Fri, Jan 27th 2012 ] - Market Wire

Illuminaas Board of Directors to Review Unsolicited Tender Offer from Roche

[ Fri, Jan 27th 2012 ] - Market Wire

ZOLL Medical, Vistaprint NV, Corning, Apple and Google

[ Fri, Jan 27th 2012 ] - Market Wire

BIOLASE Signs Strategic Sales and Marketing Partn .. udy Club, a Leading Dental Education Organization

[ Fri, Jan 27th 2012 ] - Market Wire

Medtronic Launches New Minimally Invasive Cardiac .. lusive Distribution Agreement with Miami Instrume

[ Fri, Jan 27th 2012 ] - Market Wire

Boston Scientific, Sirius, Momenta Pharmaceuticals, Gran Tierra Energy, Taseko Mines and TiVo

[ Fri, Jan 27th 2012 ] - Market Wire

Reduce Stress and Help Shoo the Flu

[ Fri, Jan 27th 2012 ] - Market Wire

Centene Corporation to Present at UBS 2012 Healthcare Conference

[ Fri, Jan 27th 2012 ] - Market Wire

CooperVisiona" Helps the Association for the Blind and Visually Impaired

[ Fri, Jan 27th 2012 ] - Market Wire

Tornier Announces 2011 Fourth Quarter and Full Year Conference Call

[ Fri, Jan 27th 2012 ] - Market Wire

WellPoint Launches Innovative Reimbursement Initi .. y Care Physicians to Improve Quality and Reduce M

[ Fri, Jan 27th 2012 ] - Market Wire

GenVec Extends Research Collaboration with Global Pharmaceutical Company

[ Fri, Jan 27th 2012 ] - Market Wire

iBio, Inc. Listing Deficiency Resolved

[ Fri, Jan 27th 2012 ] - Market Wire

Infinity Reports Update from Phase 2 Study of Sar .. ine in Patients with Metastatic Pancreatic Cancer

[ Fri, Jan 27th 2012 ] - Market Wire

El estudio ASCEND evaluar la eficacia de TYSABRI .. o para la esclerosis mltiple secundaria progresiv

[ Fri, Jan 27th 2012 ] - Market Wire

Independent Data Published on BioLife Solutions HypoThermosol and CryoStor

[ Fri, Jan 27th 2012 ] - Market Wire

Dr. Reddyas Clarifies Media Reports

Thu, January 26, 2012

[ Thu, Jan 26th 2012 ] - Market Wire

Aetna Announces Transaction with Vitality Re III

[ Thu, Jan 26th 2012 ] - Market Wire

Theratechnologies to Announce Results for Its 2011 Fiscal Year

[ Thu, Jan 26th 2012 ] - Market Wire

Vista Partners Updates Coverage on OncoSec Medical Inc.;; Target Price $2.50

[ Thu, Jan 26th 2012 ] - Market Wire

Align Technology, Zeltiq Aesthetics & Others

[ Thu, Jan 26th 2012 ] - Market Wire

Align Technology, Zeltiq Aesthetics amp;; Others

[ Thu, Jan 26th 2012 ] - Market Wire

BioReference to Launch Groundbreaking Solid Tumor .. ping Test through its GenPath Oncology Laboratory

[ Thu, Jan 26th 2012 ] - Market Wire

Study Highlights CyberKnife SBRT Benefits for Treatment of Central Lung Tumors

[ Thu, Jan 26th 2012 ] - Market Wire

Merck to Hold 2011 Full-Year and Fourth-Quarter Sales and Earnings Conference Call on February 2

[ Thu, Jan 26th 2012 ] - Market Wire

Lo studio ASCEND valuter l'efficacia di TYSABRI ( .. o per la sclerosi multipla secondariamente progre

[ Thu, Jan 26th 2012 ] - Market Wire

tude ASCEND pour valuer l'efficacit de TYSABRI (n .. ement pour la sclrose en plaques progressive seco

[ Thu, Jan 26th 2012 ] - Market Wire

ASCEND-Studie zur Prfung der Wirksamkeit von TYSA .. herapie fr sekundr-progrediente Multiple Sklerose

[ Thu, Jan 26th 2012 ] - Market Wire

Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimeras Care

[ Thu, Jan 26th 2012 ] - Market Wire

NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign

[ Thu, Jan 26th 2012 ] - Market Wire

Celgene to Acquire Avila Therapeutics

[ Thu, Jan 26th 2012 ] - Market Wire

Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX Phase Ib Cellulite Study

[ Thu, Jan 26th 2012 ] - Market Wire

Nutraceutical Reports Fiscal 2012 Q1 Results

[ Thu, Jan 26th 2012 ] - Market Wire

Soligenix Receives $574,000 in Non-Dilutive Finan .. hnology Business Tax Certificate Transfer Program

[ Thu, Jan 26th 2012 ] - Market Wire

Initial Clinical Data Reveal Potential of Tasimel .. the Body Clock in Non-24-Hour Sleep-Wake Disorder

[ Thu, Jan 26th 2012 ] - Market Wire

Illumina Adopts Stockholder Rights Agreement

Wed, January 25, 2012

[ Wed, Jan 25th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of TranS1 Inc.

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead start een Fase 2 klinisch onderzoek voor d .. n lage-dosis nieuwe prodrug van Tenofovir voor de

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead avvia una sperimentazione clinica di Fase .. 340, un nuovo profarmaco di tenofovir a basso dos

[ Wed, Jan 25th 2012 ] - Market Wire

Law Firm Brower Piven Announces Investigation in .. e Possible Acquisition of Illumina, Inc. by Roche

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead inicia ensayo clnico de Fase 2 que evala G .. e baja dosis de tenofovir para el tratamiento del

[ Wed, Jan 25th 2012 ] - Market Wire

Harwood Feffer LLP Announces Investigation of Illumina Inc.

[ Wed, Jan 25th 2012 ] - Market Wire

Thoratec Schedules Fourth Quarter Conference Call, Webcast

[ Wed, Jan 25th 2012 ] - Market Wire

Investigation of Chemed Corporation Shareholder Claims by Goldfarb Branham Law Firm LLP

[ Wed, Jan 25th 2012 ] - Market Wire

ZELTIQ spant rechtszaak aan tegen Clinipro wegens patentinbreuk

[ Wed, Jan 25th 2012 ] - Market Wire

Neurocrine Biosciences Announces The FDA Has Gran .. t Track Designation For VMAT2 Inhibitor NBI-98854

[ Wed, Jan 25th 2012 ] - Market Wire

Medtronic and Guided Therapeutics Poised for Growth

[ Wed, Jan 25th 2012 ] - Market Wire

Digirad Receives CE Mark Approval for Advanced, Solid-State Cardius(R) X-ACT Imaging System

[ Wed, Jan 25th 2012 ] - Market Wire

ZELTIQ Initiates Patent Infringement Lawsuit Against Clinipro

[ Wed, Jan 25th 2012 ] - Market Wire

Dados Clnicos para o Estudo da DURABILIDADE II Apresentado na ISET 2012

[ Wed, Jan 25th 2012 ] - Market Wire

Donnes cliniques pour l'tude DURABILITY II prsente lors de l'ISET 2012

[ Wed, Jan 25th 2012 ] - Market Wire

FDA actualiseert TYSABRI (natalizumab) label en v .. s antilichaam status toe als een PML risicofactor

[ Wed, Jan 25th 2012 ] - Market Wire

Marina Biotech Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508

[ Wed, Jan 25th 2012 ] - Market Wire

DaVita Acquires Majority Stake in NephroLife India

[ Wed, Jan 25th 2012 ] - Market Wire

Cord Blood America Reports that Umbilical Cord Bl .. Used in Experimental Effort to Treat Type 1 Diabe

Tue, January 24, 2012

[ Tue, Jan 24th 2012 ] - Market Wire

Quarterly Report I 11/12

[ Tue, Jan 24th 2012 ] - Market Wire

Codexis Announces CFO Departure

[ Tue, Jan 24th 2012 ] - Market Wire

Mylan to Host Investor Day on Feb. 21, 2012, in New York City

[ Tue, Jan 24th 2012 ] - Market Wire

Oramed Pharmaceuticals Granted Australian Patent .. pany's Core Technology in Oral Delivery of Protei

[ Tue, Jan 24th 2012 ] - Market Wire

Cleveland BioLabs Announces Management Reorganization

[ Tue, Jan 24th 2012 ] - Market Wire

Critical Outcome Technologies Inc. Initiates Preclinical Testing of AML Drug Candidates

[ Tue, Jan 24th 2012 ] - Market Wire

Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors

[ Tue, Jan 24th 2012 ] - Market Wire

Booming Stem Cell Market Benefits Advanced Cell Technology and Neostem

[ Tue, Jan 24th 2012 ] - Market Wire

Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry

[ Tue, Jan 24th 2012 ] - Market Wire

Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients

[ Tue, Jan 24th 2012 ] - Market Wire

Adipose Stem Cell Heart Attack Trial Data Publish .. College of Cardiology;; Cytori's APOLLO T

[ Tue, Jan 24th 2012 ] - Market Wire

Spectranetics Strengthens Peripheral Vascular Por .. a Partnership to Distribute the TAPASa" Catheter

[ Tue, Jan 24th 2012 ] - Market Wire

BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C

[ Tue, Jan 24th 2012 ] - Market Wire

PDL BioPharma Announces 2012 Regular Quarterly Dividends

[ Tue, Jan 24th 2012 ] - Market Wire

Quest Diagnostics Increases Share Repurchase Authority by $1 Billion

[ Tue, Jan 24th 2012 ] - Market Wire

Covidien verffentlicht klinische Daten ber Plaque-Exzision zur Behandlung kalzifizierter Lsionen

[ Tue, Jan 24th 2012 ] - Market Wire

TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City

[ Tue, Jan 24th 2012 ] - Market Wire

OncoSec to Present at World Cancer Immunotherapy Conference

[ Tue, Jan 24th 2012 ] - Market Wire

Dhr. Richard W. Barker wordt lid Raad van Bestuur van Celgene Corporation

Mon, January 23, 2012

[ Mon, Jan 23rd 2012 ] - Market Wire

Revoici la dpche corrige : Celgene Corporation li .. W. Barker, D. Phil., son conseil d'administration

[ Mon, Jan 23rd 2012 ] - Market Wire

Celgene Corporation incorpora a su Consejo de Administracin al Dr. Richard W. Barker

[ Mon, Jan 23rd 2012 ] - Market Wire

Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc.

[ Mon, Jan 23rd 2012 ] - Market Wire

Fresh Start Private Renews Advertising Agreement With Clear Channel Los Angeles Until 2013

[ Mon, Jan 23rd 2012 ] - Market Wire

UnitedHealth Group, The Goldman Sachs, Tiffany & Company, News Corporation and School Specialty

[ Mon, Jan 23rd 2012 ] - Market Wire

Verisante Aura Clinical Study Data Analysis Presented at SPIE

[ Mon, Jan 23rd 2012 ] - Market Wire

Radient Pharmaceuticals Presented Two Abstracts a .. testinal Cancers Symposium (ASCO) on Jan 21, 2012

[ Mon, Jan 23rd 2012 ] - Market Wire

OPKO Health Acquires Next Generation Prostate Cancer Tests

[ Mon, Jan 23rd 2012 ] - Market Wire

Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board

[ Mon, Jan 23rd 2012 ] - Market Wire

Medtronic Announces 510(k) Clearance for the Aqua .. SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery

[ Mon, Jan 23rd 2012 ] - Market Wire

Canada's First National Public Cord Blood Bank Ad .. ThermoGenesis BioArchive Cryopreservation System

[ Mon, Jan 23rd 2012 ] - Market Wire

MyMedicalRecords to Introduce Mobile Phone and Tablet App at HIMSS

[ Mon, Jan 23rd 2012 ] - Market Wire

Boston Scientific Announces Favorable Ruling in Patent Infringement Case

[ Mon, Jan 23rd 2012 ] - Market Wire

Amarantus BioSciences Licenses Parkinsonas Diseas .. ostic Biomarker Test from Power3 Medical Products

[ Mon, Jan 23rd 2012 ] - Market Wire

The Medicines Company Settles Angiomax(R) (Bivali .. udin) Patent Litigations With App Pharmaceuticals

[ Mon, Jan 23rd 2012 ] - Market Wire

EntreMed Secures $10 Million Strategic Financing

[ Mon, Jan 23rd 2012 ] - Market Wire

Marina Biotech Receives Notice of Acceptance for .. g Its Unlocked Nucleobase Analog (UNA) Technology

[ Mon, Jan 23rd 2012 ] - Market Wire

BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board

[ Mon, Jan 23rd 2012 ] - Market Wire

PAREXEL Expands Alliance Network to Support Early .. lishes Collaboration With University Hospitals Br

Sun, January 22, 2012

[ Sun, Jan 22nd 2012 ] - Market Wire

Helix BioPharma Corp. Responds to Dissident Proxy .. ion With the January 30, 2012 Shareholder Meeting

Sat, January 21, 2012

[ Sat, Jan 21st 2012 ] - Market Wire

L'FDA aggiorna l'etichetta del TYSABRI (natalizum .. egli anticorpi anti-JCV come fattore di rischio d

[ Sat, Jan 21st 2012 ] - Market Wire

FDA aktualisiert Produktinformationen fr TYSABRI .. des JC-Virus-Antikrperstatus als Risikofaktor fr

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l' .. zumab) pour y inclure le statut daanticorps anti-

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. de TYSABRI (natalizumab) pour y inclure le statut

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;tiquetage de TYSABRI (natalizumab) p

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;tiquetage de TYSABRI (na

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;tiquetage de TYS

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;tiquetage de

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;tiquetag

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;tiqu

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&

[ Sat, Jan 21st 2012 ] - Market Wire

La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&

Fri, January 20, 2012

[ Fri, Jan 20th 2012 ] - Market Wire

Select Medical Holdings Corporation to Announce F .. d Full Year 2011 Results on Thursday, February 23

[ Fri, Jan 20th 2012 ] - Market Wire

FDA Advisory Committee Declines to Recommend Appr .. Gel 8% for the Reduction of Risk of Preterm Birth

[ Fri, Jan 20th 2012 ] - Market Wire

FDA Updates TYSABRI (natalizumab) Label to Includ .. nti-JC Virus Antibody Status as a PML Risk Factor

[ Fri, Jan 20th 2012 ] - Market Wire

Bestuursvoorzitter van Covidien gekozen tot Voorzitter van de Raad

[ Fri, Jan 20th 2012 ] - Market Wire

Waters and NIBRT Complete Work on World's First UPLC Glycan Database

[ Fri, Jan 20th 2012 ] - Market Wire

Sequenom Prices Public Offering of Common Stock

[ Fri, Jan 20th 2012 ] - Market Wire

CareFusion Provides Update on Voluntary Recall of Neurological Monitoring Software and Devices

[ Fri, Jan 20th 2012 ] - Market Wire

Amerigroup Corporation to Discuss Fourth Quarter Earnings on February 17

[ Fri, Jan 20th 2012 ] - Market Wire

La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist

[ Fri, Jan 20th 2012 ] - Market Wire

Hartford Hospital Selected as a Hansen Medical "C .. llence" for Sensei(R) X Robotic Catheter Platform

[ Fri, Jan 20th 2012 ] - Market Wire

Genomic Health Presents Results From First Clinic .. ncotype DX Colon Cancer at the 2012 Gastrointesti

[ Fri, Jan 20th 2012 ] - Market Wire

Insmed Incorporated Provides Corporate Update

[ Fri, Jan 20th 2012 ] - Market Wire

INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA

[ Fri, Jan 20th 2012 ] - Market Wire

Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN

[ Fri, Jan 20th 2012 ] - Market Wire

Director general de Covidien designado presidente del Directorio

[ Fri, Jan 20th 2012 ] - Market Wire

Covidien CEO Elected Chairman of the Board

[ Fri, Jan 20th 2012 ] - Market Wire

Covidien: amministartore delegato eletto presidente del consiglio d'amministrazione

[ Fri, Jan 20th 2012 ] - Market Wire

Le PDG de Covidien est lu prsident du conseil daadministration

[ Fri, Jan 20th 2012 ] - Market Wire

Covidien-CEO zum Chairman of the Board gewhlt

Thu, January 19, 2012

[ Thu, Jan 19th 2012 ] - Market Wire

U.S. Food and Drug Administration keurt nieuwe fo .. an Viread goed voor gebruik door kinderen met hiv

[ Thu, Jan 19th 2012 ] - Market Wire

US-Arzneimittelbehrde FDA genehmigt neue Rezeptur .. Viread zur Anwendung bei HIV-infizierten Kindern

[ Thu, Jan 19th 2012 ] - Market Wire

LaAgenzia per gli Alimenti e i Medicinali statuni .. tration, FDA) approva delle nuove formulazioni di

[ Thu, Jan 19th 2012 ] - Market Wire

LaAgenzia per gli Alimenti e i Medicinali statuni .. ration,;;;;;;; FDA) appr

[ Thu, Jan 19th 2012 ] - Market Wire

LaAgenzia per gli Alimenti e i Medicinali statuni .. ration,;;;;;;;;; F

[ Thu, Jan 19th 2012 ] - Market Wire

LaAgenzia per gli Alimenti e i Medicinali statuni .. ration,;;;;;;;;;

[ Thu, Jan 19th 2012 ] - Market Wire

LaAgenzia per gli Alimenti e i Medicinali statuni .. ration,;;;;;;;;;

[ Thu, Jan 19th 2012 ] - Market Wire

LaAgenzia per gli Alimenti e i Medicinali statuni .. ration,;;;;;;;;;

[ Thu, Jan 19th 2012 ] - Market Wire

LaAgenzia per gli Alimenti e i Medicinali statuni .. ration,;;;;;;;;;

[ Thu, Jan 19th 2012 ] - Market Wire

LaAgenzia per gli Alimenti e i Medicinali statuni .. ration,;;;;;;;;;

[ Thu, Jan 19th 2012 ] - Market Wire

Alnylam to Restructure Organization, Aligning Res .. Value Pipeline Opportunities in aAlnylam 5x15a"a

[ Thu, Jan 19th 2012 ] - Market Wire

Covidien gibt vierteljhrliche Bardividende bekannt

[ Thu, Jan 19th 2012 ] - Market Wire

Aetna and Heartland Health Roll out New Health Plan

[ Thu, Jan 19th 2012 ] - Market Wire

Clovis Oncology Announces FDA Acceptance of Inves .. on for Oral EGFR Mutant-Selective Inhibitor CO-16

[ Thu, Jan 19th 2012 ] - Market Wire

Amica Mature Lifestyles Announces Completion of A .. etirement Residence and Issuance of Common Shares

[ Thu, Jan 19th 2012 ] - Market Wire

NuPathe Announces Allowance of Additional U.S. Patent Application for Its Migraine Patch

[ Thu, Jan 19th 2012 ] - Market Wire

Amerigroup Investor Relations Kick Off 2012 with High Honors

Hologic to Participate in Four Investor Conferences

_{//health-fitness.news-articles.net/content/2012/ .. to-participate-in-four-investor-conferences.html}
^{Published in Health and Fitness on Wednesday, January 25th 2012 at 14:38 GMT by Market Wire}

Hologic to Participate in Four Investor Conferences -- BEDFORD, Mass., Jan. 25, 2012 /PRNewswire/ --

Hologic to Participate in Four Investor Conferences

[ ]

BEDFORD, Mass., Jan. 25, 2012 /PRNewswire/ -- Hologic, Inc. (NASDAQ: [ HOLX ]) today announced that company management will participate in the following investor conferences:

Glenn Muir, Executive Vice President and Chief Financial Officer, will present at:
- The Leerink Swann 2012 Global Healthcare Conference in New York City, New York on Wednesday, February 15, 2012 at 11:30 a.m. (Eastern).
- The 2012 RBC Capital Markets' Global Healthcare Conference in New York City, New York on Tuesday, February 28, 2012 at 9:30 a.m. (Eastern).
Rob Cascella, President and Chief Executive Officer, will present at:
- The Citi 2012 Global Health Care Conference in New York City, New York on Monday, February 27, 2012 at 9:30 a.m. (Eastern).
- The Barclays Capital Global Healthcare Conference in Miami, Florida on Tuesday, March 13, 2012 at 8:00 a.m. (Eastern).

Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at [ www.hologic.com/investors-overview ]. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit [ www.hologic.com ].

Contact:
Deborah Gordon
Vice President, Investor Relations
Hologic, Inc.
(781) 999-7716

SOURCE Hologic, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.hologic.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire